Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02710162 · ClinicalTrials.gov registry record · Early Phase 1
Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)
A Early Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 21
- Enrollment target
NCT02710162 is a Early Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 21 participants.
The verdict
NCT02710162, a Early Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
Individuals with th Amyotrophic Lateral Sclerosis are at high risk for swallowing impairment (dysphagia) which leads to malnutrition, decreased pulmonary health, aspiration and aspiration pneumonia. These sequelae necessitate timely identification of at risk individuals to ensure optimal management of oral intake and pulmonary function. The purpose of this study is to evaluate the discriminant ability of several non-invasive screening tools at detecting swallowing impairment in individuals with ALS.
Interventions
- DEVICE Electrical Impedance Myography
- DRUG Capsaicin
- PROCEDURE Videofluoroscopic Swallowing Study
- DEVICE Iowa Oral Performance Instrument
- DEVICE Micro Mouth Pressure Meter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-12-19 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02710162
The ClinicalTrials.gov registry entry for NCT02710162 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Electrical Impedance Myography is the first listed.
NCT02710162 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02710162 about?
NCT02710162 is a clinical study titled "Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)". Individuals with th Amyotrophic Lateral Sclerosis are at high risk for swallowing impairment (dysphagia) which leads to malnutrition, decreased pulmonary health, aspiration and aspiration pneumonia. These sequelae necessitate timely identification of at risk individuals to ensure optimal management ...
What is the current status of trial NCT02710162?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 21 participants. The study started on 2016-04. Estimated completion is 2017-12-19.
What interventions are being tested in trial NCT02710162?
The interventions under investigation include: Electrical Impedance Myography (DEVICE), Capsaicin (DRUG), Videofluoroscopic Swallowing Study (PROCEDURE), Iowa Oral Performance Instrument (DEVICE), Micro Mouth Pressure Meter (DEVICE).
Who is sponsoring clinical trial NCT02710162?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.